US9265635B2 - Stent having removable anchoring element - Google Patents
Stent having removable anchoring element Download PDFInfo
- Publication number
- US9265635B2 US9265635B2 US14/197,766 US201414197766A US9265635B2 US 9265635 B2 US9265635 B2 US 9265635B2 US 201414197766 A US201414197766 A US 201414197766A US 9265635 B2 US9265635 B2 US 9265635B2
- Authority
- US
- United States
- Prior art keywords
- stent
- anchoring element
- support structure
- tubular support
- stents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000004873 anchoring Methods 0.000 title claims abstract description 44
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 11
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical group [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 10
- 229910001220 stainless steel Inorganic materials 0.000 claims description 7
- 239000010935 stainless steel Substances 0.000 claims description 7
- 239000000835 fiber Substances 0.000 claims description 5
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- 229910000861 Mg alloy Inorganic materials 0.000 claims 2
- 230000000112 colonic effect Effects 0.000 claims 1
- 230000002183 duodenal effect Effects 0.000 claims 1
- -1 poly(alpha-hydroxy acid) Polymers 0.000 description 26
- 239000000463 material Substances 0.000 description 20
- 238000013508 migration Methods 0.000 description 7
- 230000005012 migration Effects 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 238000010276 construction Methods 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 239000000788 chromium alloy Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 3
- 239000007769 metal material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920001610 polycaprolactone Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- 229910001226 L605 Inorganic materials 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 229920002732 Polyanhydride Polymers 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 2
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 239000000622 polydioxanone Substances 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000431 shape-memory polymer Polymers 0.000 description 2
- 229910000619 316 stainless steel Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 229920001744 Polyaldehyde Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical class [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000010329 laser etching Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 125000005487 naphthalate group Chemical group 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 description 1
- 229920001072 poly(l-lactide-co-caprolactone) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/044—Oesophagi or esophagi or gullets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/848—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
- A61F2002/8483—Barbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0008—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0069—Three-dimensional shapes cylindrical
Definitions
- stents Medical prostheses frequently referred to as stents are well known and commercially available. These devices are used within body vessels of humans for a variety of medical applications. Examples include intravascular stents for treating stenoses, stents for maintaining openings in the urinary biliary, tracheobronchial, esophageal, and renal tracts, and vena cava filters. Stents may also be used by physicians for malignant tumors. Benign tumors are seldom stented with metal platforms.
- a stent is delivered into position at a treatment site in a compressed state using a delivery device. After the stent is positioned at the treatment site, the delivery device is actuated to release the stent. Following release of the stent, self-expanding stents are allowed to self-expand within the body vessel. Alternatively, a balloon may be used to expand other types of stents. This expansion of the stent in the body vessel helps to retain the stent in place and prevent movement or migration of the stent. Stents are typically composed of stent filaments.
- Stents may be categorized as permanent, removable or bioresorbable. Permanent stents are retained in place and incorporated into the vessel wall. Removable stents are removed from the body vessel when the stent is no longer needed.
- a bioresorbable stent may be composed of, or include, biodegradable material or bioresorbable material which is broken down by the body and absorbed or passed from the body when it is no longer needed.
- stent filaments Commonly used materials for known stent filaments include Elgiloy® and Phynox® metal spring alloys. Other metallic materials that may be used for stents filaments are 316 stainless steel, MP35N alloy and superelastic Nitinol nickel-titanium alloy. Another stent, available from Schneider (USA) Inc. of Minneapolis, Minn., has a radiopaque clad composite structure such as shown in U.S. Pat. No. 5,630,840 to Mayer. Stents can also be made of a titanium alloy as described in U.S. Pat. No. 5,888,201.
- Bioabsorbable implantable endoprostheses such as stents, stent-grafts, grafts, filters, occlusive devices, and valves may be made of poly(alpha-hydroxy acid) such as poly-L-lactide (PLLA), poly-D-lactide (PDLA), polyglycolide (PGA), polydioxanone, polycaprolactone, polygluconate, polylactic acid-polyethylene oxide copolymers, modified cellulose, collagen, poly(hydroxybutyrate), polyanhydride, polyphosphoester, poly(aminoacides), or related coploymers materials, each of which have a characteristic degradation rate in the body.
- PLLA poly-L-lactide
- PDLA poly-D-lactide
- PGA polydioxanone
- polycaprolactone polygluconate
- polylactic acid-polyethylene oxide copolymers modified cellulose
- collagen collagen
- polyanhydride poly
- Stents may also be covered with various materials to encourage or inhibit tissue attachment to the stent. Covered stents are gaining, favor for biliary applications because they more effectively inhibit tissue attachment, intrusion, and constriction of the tract than bare stents. For example, polytetrafluoroethylene (PTFE) covered stents are desirable for removable stents because tissue attachment or in-growth is reduced in comparison to bare stent or a stent covered with textile (polyester) material. Laminated ePTFE may also be used to cover stents.
- PTFE polytetrafluoroethylene
- covered stents which include characteristics to maintain the stent in position at the treatment site.
- Stents are also particularly susceptible to migration when used in certain parts of the body such as the esophageal tract.
- stent anchors to prevent stent migration is also problematic, as such anchors generally permit tissue in-growth into the stent, thereby preventing stent migration, but at the same time making removal and/or repositioning of the stent difficult or dangerous.
- the present invention relates to a stent comprising a radially expandable elongate tubular support structure, the elongate tubular support structure comprising an inner surface and an outer surface and an anchoring element disposed on at least a portion of the outer surface of the tubular support structure, the anchoring element is separate and removable from the elongate tubular support structure.
- the present invention relates to a stent comprising a radially expandable elongate tubular support structure, the elongate tubular support structure comprising a braided or woven open network of fibers or filaments and an anchoring element interwoven with the braided or woven open network, the anchoring element is separate and removable from said elongate tubular support structure.
- the present invention relates a stent comprising a radially expandable elongate tubular support structure, the elongate tubular support structure comprising an inner surface and an outer surface and an anchoring element disposed on said at least a portion of said outer surface of said tubular support structure, the anchoring element is separate and removable from said elongate tubular support structure, the anchoring element is in the shape of a nail or staple, the nail or staple is positioned on the stent after the stent has been deployed in the lumen of a patient.
- FIG. 1 is a side view of a stent having a removable anchor element incorporated thereon.
- FIG. 2 is a side view of a stent similar to that in FIG. 1 in combination with a removal tool for removing the removable anchor element from the patient's body.
- FIG. 3 is a side view of the stent and removal tool similar to that shown in claim 2 with the removable anchor being partially removed from the stent.
- FIG. 4 is a side view of a generic woven stent having a removable anchor element interwoven in the braided pattern of the stent.
- FIG. 5 is a side view of a covered stent wherein the covering is disposed on the inner surface of the stent.
- FIG. 6 is taken at section 6 is FIG. 5 and is an enlarged view of the stent wall illustrating the stent embedded in the covering material.
- FIG. 7 is a perspective view of an alternative embodiment of a woven or braided stent having a flared proximal end.
- FIG. 8 is a perspective view of a stent illustrating alternative embodiments of temporary anchoring elements.
- FIG. 1 illustrates one embodiment of a stent support structure 10 having a removable anchoring element 12 disposed thereon. Any number of methods can be employed to removably attach the removable anchoring element to the stent 10 .
- the removable anchoring element 12 provides robust attachment of the stent 10 to the body organ targeted for treatment.
- the removable anchoring element 12 is designed to be readily removed from the stent 10 prior to removal of the stent 10 from the patient's body. In some embodiments, the removable anchoring element is therefore separate from and in contact with but unattached to the stent 10 .
- the anchoring element may be temporarily attached by alternative mechanical means such as clips, springs or interlocking features which may be disengaged and removed by the physician. Attachment of the anchoring element may be facilitated by the use of temporary adhesive or structures that degrade with exposure to the bodies environment.
- removable anchoring element 12 is in the form of a wire which may be round or flat.
- Stent 10 may be coiled or patterned as a braided or woven open network of wires, fibers or filaments interwoven in a braided pattern to form a tubular stent 10 , as disclosed, for example, in commonly assigned U.S. Patent Publication No. 2012/0128793, the entire content of which is incorporated by reference herein. Similar stent constructions are also disclosed in commonly assigned U.S. Patent Publication Nos.
- the stent may also be fabricated from a cut metal tube such as a slotted tube or tubes formed with serpentine structures of straight and curved strut configurations such as those made for vascular applications.
- a cut metal tube such as a slotted tube or tubes formed with serpentine structures of straight and curved strut configurations such as those made for vascular applications.
- These stents can be made of stainless steel, nitinol, cobalt-chromium alloys or other materials known in the art and then laser cut into the desired stent geometry.
- the removable anchoring element 12 may extend in the direction of the longitudinal axis of the stent and can be interwoven in the braided construction of the stent 10 .
- Wires extending in the longitudinal direction of the stent 10 are advantageous in that they require less space when the stent is compressed and allow for smaller delivery system diameters than wires having a circumferential component.
- any number of wires can be employed.
- a minimum of two wires are positioned symmetrically about the circumference of the stent 10 to provide uniform anchoring in a body vessel.
- the lumen wall anchor points may be located not only at the middle or end portions of the stent, but at any other portion of the stent as well.
- any number of wires may be employed such as 3, 4, 5, 6 and so forth.
- a single circumferential ring of anchoring elements may be positioned in the middle of the stent to prevent stent “walking” which may occur if anchoring elements are positioned at both ends of the stent.
- FIG. 8 is representative of alternative embodiments wherein stent 10 has a temporary anchor 32 that is “pre-attached” to the stent in the form of a circumferential anchor 32 .
- a temporary anchor 34 in the form of staples or nails may be disposed on stent 10 after stent 10 has been deployed in the body at the treatment site.
- the staples 34 can be removed when it is desirable to remove stent 10 from the body.
- the nails or staples 34 are disposed on the proximal end of the stent.
- the nails or staples can be disposed on the center portion, the distal portion, or any combination of the three portions as well.
- the circumferential anchor 32 and the staples or nails 34 can be employed in separate embodiments of stent 10 , rather than in combination as shown in FIG. 8 .
- the temporary anchor 34 or the nails or staples 34 shown in FIG. 8 on a stent having a flared proximal end can be employed on any other stent configuration as well.
- the removable anchoring element 12 may be constructed such that the ends of the wire are positioned at the ends of the stent 10 . However, the removable anchoring element 12 may be constructed such that the ends of the wire are positioned at any portion of the stent 10 where anchoring is needed.
- Stent can be formed from any suitable stent material including, but not limited to, shape memory metals such as Nitinol, cobalt-chromium alloys such as Elgiloy® or L605, stainless steel, nickel, titanium, polymers, shape memory polymers, etc.
- shape memory metals such as Nitinol, cobalt-chromium alloys such as Elgiloy® or L605, stainless steel, nickel, titanium, polymers, shape memory polymers, etc.
- the removable anchoring element 12 can similarly be made of any suitable stent material including, but not limited to, shape memory metals such as Nitinol, cobalt-chromium alloy such as Elgiloy or Alloy L605, stainless steel, nickel, titanium, polymers, shape memory polymers, etc.
- shape memory metals such as Nitinol, cobalt-chromium alloy such as Elgiloy or Alloy L605, stainless steel, nickel, titanium, polymers, shape memory polymers, etc.
- nitinol wires are woven into the braided structure of the stent 10 in a longitudinal pattern.
- stainless steel has been found to be beneficial where increased stiffness when smaller volumes are desired.
- a removal tool 14 such as rat tooth retrieval forceps, a snare or a basket can be used to grasp the removable anchor element 12 and pull it in the proximal direction of the stent 10 to remove it from the patient's body. Specially designed tools to locate and withdraw the temporary anchor may also be envisioned.
- the removable anchor element 12 is grasped by removal tool 14 in the central portion of the stent and at approximately the middle portion of the removable anchor element 12 .
- the anchoring element 12 is designed to fold in the middle such as by reducing the amount of material or by providing a strain relief such as by scoring or providing depressions or grooves in the wire to allow the middle portion to bend more readily.
- Reducing material in the middle of the wire can be done using any suitable method known in the art such as by laser etching, grinding, and so forth.
- the removable anchor element can be formed from polymers or metal alloys such as magnesium, which degrade in vivo at a predetermined rate allowing stent removal after a set time.
- Biodegradable or biodegradable materials are those which break down and lose their structural integrity in vivo.
- suitable biodegradable polymers include, but are not limited to, poly(amides) such as poly(amino acids) and poly(peptides), poly(esters) such as polylactide including poly(DL-lactide) and polyglycolide, and copolymers thereof such as polylactide-co-glycolide including poly(DL-lactide-co-glycolide), poly(L-lactide-co-glycolide), poly(caprolactone) and polylactide-co-caprolactone including poly(DL-lactide-co-caprolactone and poly(L-lactide-co-caprolactone), poly(anhydrides), poly(orthoesters), poly(carbonates) including tyrosine derived polycarbonates, polyhydroxyvalerate, polyhydroxybutyrate, polyhydroxybutyrate-co-valerate, and chemical derivatives thereof (substitutions
- the removable anchor element 12 can be employed with any stent construction.
- stent 10 is a self-expanding stent formed of a shape memory metal such as nitinol having a silicone covering.
- the stent has a braided wire construction.
- stent 10 is shown having a silicone covering 12 .
- Stent 10 is disposed on silicone covering 12 and is partially embedded therein.
- FIG. 2 is a partial cross-sectional view of the stent taken at section 2 in FIG. 1 . Covered stents of this type are described in commonly assigned US Patent Publication Nos. 2006/0276887 and 2008/0009934, each of which is incorporated by reference herein in its entirety.
- any stent can have a covering and the coverings are thus not limited to nitinol stents. Moreover, the stent need not be covered whatsoever, may be partially covered or may be fully covered. The stent may also have a covering on the inside, the outside or both.
- suitable covering materials can be employed as well.
- suitable covering materials include, but are not limited to, polyethylene, polypropylene, polyvinyl chloride, polytetrafluoroethylene, including expanded polytetrafluoroethylene (ePTFE), fluorinated ethylene propylene, fluorinated ethylene propylene, polyvinyl acetate, polystyrene, poly(ethylene terephthalate), naphthalene, dicarboxylate derivatives, such as polyethylene naphthalate, polybutylene naphthalate, polytrimethylene naphthalate and trimethylenediol naphthalate, polyurethane, polyurea, polyamides, polyimides, polycarbonates, polyaldehydes, polyether ether ketone, natural rubbers, polyester copolymers, styrene-butadiene copolymers, polyethers, such as fully or partially halogenated polyethers, and copolymers and combinations thereof. See, for example
- stent 10 may have a braided construction with a flared proximal end 22 as shown in FIG. 7 .
- stent 10 is an esophageal stent.
- Stent 10 may be formed of any suitable stent material including metallic and non-metallic materials as well as shape memory materials. Examples of suitable materials include, but are not limited to, shape memory alloys such as Nitinol, other metallic materials such as stainless steel, tantalum, titanium, nickel-chrome, or cobalt-chromium alloys such as those sold under the tradename of Elgiloy®.
- Stent 10 may have a flared distal end or flared proximal and distal ends as well.
- Therapeutic agents may also be incorporated into the stent structure as is known in the art.
- the removable anchor element can be employed herein with any stent and is suitably employed with temporary stents which are removed from the patient's body after some specified period of time.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
Claims (18)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/197,766 US9265635B2 (en) | 2013-03-14 | 2014-03-05 | Stent having removable anchoring element |
US15/009,266 US9498319B2 (en) | 2013-03-14 | 2016-01-28 | Stent having removable anchoring element |
US15/340,304 US20170042708A1 (en) | 2013-03-14 | 2016-11-01 | Stent having removable anchoring element |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361783308P | 2013-03-14 | 2013-03-14 | |
US14/197,766 US9265635B2 (en) | 2013-03-14 | 2014-03-05 | Stent having removable anchoring element |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/009,266 Continuation US9498319B2 (en) | 2013-03-14 | 2016-01-28 | Stent having removable anchoring element |
Publications (2)
Publication Number | Publication Date |
---|---|
US20140277560A1 US20140277560A1 (en) | 2014-09-18 |
US9265635B2 true US9265635B2 (en) | 2016-02-23 |
Family
ID=51531359
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/197,766 Expired - Fee Related US9265635B2 (en) | 2013-03-14 | 2014-03-05 | Stent having removable anchoring element |
US15/009,266 Expired - Fee Related US9498319B2 (en) | 2013-03-14 | 2016-01-28 | Stent having removable anchoring element |
US15/340,304 Abandoned US20170042708A1 (en) | 2013-03-14 | 2016-11-01 | Stent having removable anchoring element |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/009,266 Expired - Fee Related US9498319B2 (en) | 2013-03-14 | 2016-01-28 | Stent having removable anchoring element |
US15/340,304 Abandoned US20170042708A1 (en) | 2013-03-14 | 2016-11-01 | Stent having removable anchoring element |
Country Status (1)
Country | Link |
---|---|
US (3) | US9265635B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170042708A1 (en) * | 2013-03-14 | 2017-02-16 | Boston Scientific Scimed, Inc. | Stent having removable anchoring element |
US10758380B2 (en) | 2016-12-30 | 2020-09-01 | Bvw Holding Ag | Stents with improved fixation |
US10806560B2 (en) | 2015-05-18 | 2020-10-20 | Pulmair Medical, Inc. | Implantable artificial bronchus and use of an implantable artificial bronchus |
USD902407S1 (en) | 2019-11-19 | 2020-11-17 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11266517B2 (en) | 2018-04-09 | 2022-03-08 | Boston Scientific Scimed, Inc. | Stent |
US20220142763A1 (en) * | 2013-03-15 | 2022-05-12 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
USD954953S1 (en) | 2020-11-03 | 2022-06-14 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11559412B2 (en) | 2019-01-07 | 2023-01-24 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
USD1014758S1 (en) | 2023-04-19 | 2024-02-13 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11918496B2 (en) | 2020-12-02 | 2024-03-05 | Boston Scientific Scimed, Inc. | Stent with improved deployment characteristics |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130103163A1 (en) * | 2011-10-21 | 2013-04-25 | Merit Medical Systems, Inc. | Devices and methods for stenting an airway |
CN107072774B (en) * | 2014-06-18 | 2019-09-06 | 波士顿科学国际有限公司 | Biliary tract rack |
DE102014115337A1 (en) | 2014-10-21 | 2016-04-21 | Nasib Dlaikan-Campos | Stent for splinting a vein and system for placing a stent |
US10166126B2 (en) | 2014-12-08 | 2019-01-01 | Boston Scientific Scimed, Inc. | Inflatable balloon stent |
US11123204B2 (en) * | 2015-02-06 | 2021-09-21 | Boston Scientific Scimed, Inc. | Anti-migration stent |
US10765539B2 (en) * | 2015-05-27 | 2020-09-08 | W. L. Gore & Associates, Inc. | Stent graft device with anchoring members having adjustable geometries |
WO2019023437A1 (en) | 2017-07-27 | 2019-01-31 | Boston Scientific Scimed, Inc. | Adjustable mandrel for forming stent with anti-migration features |
EP3446661B1 (en) * | 2017-08-21 | 2021-12-29 | Cook Medical Technologies LLC | Braided stent crown geometry and flare |
JP7331342B2 (en) * | 2017-09-29 | 2023-08-23 | 株式会社ジェイ・エム・エス | stent |
US11786355B2 (en) * | 2020-01-30 | 2023-10-17 | Boston Scientific Scimed, Inc. | Radial adjusting self-expanding stent with anti-migration features |
US11707368B2 (en) | 2020-02-03 | 2023-07-25 | Boston Scientific Scimed, Inc. | Stent, mandrel, and method for forming a stent with anti-migration features |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5630840A (en) | 1993-01-19 | 1997-05-20 | Schneider (Usa) Inc | Clad composite stent |
US5888201A (en) | 1996-02-08 | 1999-03-30 | Schneider (Usa) Inc | Titanium alloy self-expanding stent |
US20060276887A1 (en) | 2005-05-13 | 2006-12-07 | Boston Scientific Scimed, Inc. | Integrated stent repositioning and retrieval loop |
US20080009934A1 (en) | 2006-07-07 | 2008-01-10 | Boston Scientific Scimed, Inc. | Endoprosthesis delivery system with stent holder |
US20110270405A1 (en) * | 2010-04-30 | 2011-11-03 | Boston Scientific Scimed, Inc. | Duodenal Metabolic Stent |
US8114147B2 (en) | 2008-06-16 | 2012-02-14 | Boston Scientific Scimed, Inc. | Continuous double layered stent for migration resistance |
US20120128793A1 (en) | 2002-02-08 | 2012-05-24 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US20120184893A1 (en) * | 2009-04-03 | 2012-07-19 | Metamodix, Inc. | Anchors and methods for intestinal bypass sleeves |
US8303669B2 (en) * | 2003-12-09 | 2012-11-06 | Gi Dynamics, Inc. | Methods and apparatus for anchoring within the gastrointestinal tract |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6626939B1 (en) * | 1997-12-18 | 2003-09-30 | Boston Scientific Scimed, Inc. | Stent-graft with bioabsorbable structural support |
WO2002085254A1 (en) * | 2001-04-20 | 2002-10-31 | The Research Foundation Of State University Of Newyork | Apparatus and method for fixation of vascular grafts |
US8998973B2 (en) * | 2004-03-02 | 2015-04-07 | Boston Scientific Scimed, Inc. | Medical devices including metallic films |
TW200530881A (en) * | 2004-03-05 | 2005-09-16 | Via Tech Inc | Resume management system, method, and computer-readable medium |
US20090192588A1 (en) * | 2008-01-29 | 2009-07-30 | Taeoong Medical Co., Ltd | Biodegradable double stent |
KR100961466B1 (en) * | 2008-01-29 | 2010-06-08 | (주) 태웅메디칼 | A stent |
US9265635B2 (en) * | 2013-03-14 | 2016-02-23 | Boston Scientific Scimed, Inc. | Stent having removable anchoring element |
-
2014
- 2014-03-05 US US14/197,766 patent/US9265635B2/en not_active Expired - Fee Related
-
2016
- 2016-01-28 US US15/009,266 patent/US9498319B2/en not_active Expired - Fee Related
- 2016-11-01 US US15/340,304 patent/US20170042708A1/en not_active Abandoned
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5630840A (en) | 1993-01-19 | 1997-05-20 | Schneider (Usa) Inc | Clad composite stent |
US5888201A (en) | 1996-02-08 | 1999-03-30 | Schneider (Usa) Inc | Titanium alloy self-expanding stent |
US20120128793A1 (en) | 2002-02-08 | 2012-05-24 | Boston Scientific Scimed, Inc. | Implantable or insertable medical device resistant to microbial growth and biofilm formation |
US8303669B2 (en) * | 2003-12-09 | 2012-11-06 | Gi Dynamics, Inc. | Methods and apparatus for anchoring within the gastrointestinal tract |
US8628583B2 (en) * | 2003-12-09 | 2014-01-14 | Gi Dynamics, Inc. | Methods and apparatus for anchoring within the gastrointestinal tract |
US20060276887A1 (en) | 2005-05-13 | 2006-12-07 | Boston Scientific Scimed, Inc. | Integrated stent repositioning and retrieval loop |
US20080009934A1 (en) | 2006-07-07 | 2008-01-10 | Boston Scientific Scimed, Inc. | Endoprosthesis delivery system with stent holder |
US8114147B2 (en) | 2008-06-16 | 2012-02-14 | Boston Scientific Scimed, Inc. | Continuous double layered stent for migration resistance |
US20120184893A1 (en) * | 2009-04-03 | 2012-07-19 | Metamodix, Inc. | Anchors and methods for intestinal bypass sleeves |
US20110270405A1 (en) * | 2010-04-30 | 2011-11-03 | Boston Scientific Scimed, Inc. | Duodenal Metabolic Stent |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170042708A1 (en) * | 2013-03-14 | 2017-02-16 | Boston Scientific Scimed, Inc. | Stent having removable anchoring element |
US11752018B2 (en) * | 2013-03-15 | 2023-09-12 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
US20220142763A1 (en) * | 2013-03-15 | 2022-05-12 | Boston Scientific Scimed, Inc. | Anti-migration micropatterned stent coating |
US11096773B2 (en) | 2015-05-18 | 2021-08-24 | Pulmair Medical, Inc. | Implantable artificial bronchus and use of an implantable artificial bronchus |
US10806560B2 (en) | 2015-05-18 | 2020-10-20 | Pulmair Medical, Inc. | Implantable artificial bronchus and use of an implantable artificial bronchus |
US10758380B2 (en) | 2016-12-30 | 2020-09-01 | Bvw Holding Ag | Stents with improved fixation |
US11986407B2 (en) | 2018-04-09 | 2024-05-21 | Boston Scientific Scimed, Inc. | Stent |
US11266517B2 (en) | 2018-04-09 | 2022-03-08 | Boston Scientific Scimed, Inc. | Stent |
US11890212B2 (en) | 2018-04-09 | 2024-02-06 | Boston Scientific Scimed, Inc. | Stent |
US11559412B2 (en) | 2019-01-07 | 2023-01-24 | Boston Scientific Scimed, Inc. | Stent with anti-migration feature |
USD902407S1 (en) | 2019-11-19 | 2020-11-17 | Pulmair Medical, Inc. | Implantable artificial bronchus |
USD954953S1 (en) | 2020-11-03 | 2022-06-14 | Pulmair Medical, Inc. | Implantable artificial bronchus |
US11918496B2 (en) | 2020-12-02 | 2024-03-05 | Boston Scientific Scimed, Inc. | Stent with improved deployment characteristics |
USD1014758S1 (en) | 2023-04-19 | 2024-02-13 | Pulmair Medical, Inc. | Implantable artificial bronchus |
USD1039157S1 (en) | 2023-04-19 | 2024-08-13 | Pulmair Medical, Inc. | Implantable artificial bronchus |
Also Published As
Publication number | Publication date |
---|---|
US20140277560A1 (en) | 2014-09-18 |
US20160151146A1 (en) | 2016-06-02 |
US9498319B2 (en) | 2016-11-22 |
US20170042708A1 (en) | 2017-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9498319B2 (en) | Stent having removable anchoring element | |
US11717424B2 (en) | Anti-migration stent with quill filaments | |
US9326870B2 (en) | Biodegradable stent having non-biodegradable end portions and mechanisms for increased stent hoop strength | |
US8444688B2 (en) | Covered stents with degradable barbs | |
JP5260964B2 (en) | Implantable expandable band | |
CA2283728C (en) | Helical mesh endoprosthesis and methods of use | |
JP2005510260A (en) | Controlled inflatable stent | |
EP2741716A1 (en) | Wing bifurcation reconstruction device | |
US12064333B2 (en) | Stent with atraumatic spacer | |
WO2015195354A1 (en) | Blood filter with scaffolds configured for extended implanted duration before retrieval | |
US11672683B2 (en) | Bifunctional balloon-expandable and self-expandable stent | |
JP2023063278A (en) | stent | |
AU2002228982A1 (en) | Stent with controlled expansion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WALAK, STEVEN E.;REEL/FRAME:032362/0618 Effective date: 20140304 |
|
ZAAA | Notice of allowance and fees due |
Free format text: ORIGINAL CODE: NOA |
|
ZAAB | Notice of allowance mailed |
Free format text: ORIGINAL CODE: MN/=. |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20240223 |